Treatment of sleep apnea improves glucose levels in prediabetes

May 20, 2013, American Thoracic Society

Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in Philadelphia.

", a condition associated with breathing disturbances during sleep is known to be associated with abnormalities in , but whether treatment of sleep apnea has any beneficial effects on glucose metabolism is still under investigation" said lead author Sushmita Pamidi, MD, of the Department of Medicine at McGill University in Montreal, Canada-"We have studied patients with sleep apnea and prediabetes, a condition defined as higher than normal but not high enough to be considered diabetes. We found that optimal treatment of sleep apnea with continuous positive airway pressure (CPAP) for two weeks led to significant improvements in glucose levels following an oral glucose challenge without affecting insulin secretion, suggesting an improvement in insulin sensitivity."

Insulin is a hormone produced in the pancreas that regulates the metabolism of glucose in the body. is a condition in which normal amounts of insulin are not adequate to produce a normal cellular insulin response to glucose ingestion. Low insulin sensitivity, a measure of how sensitive a person's body is to the effects of insulin, is associated with the development of type 2 diabetes.

As many as two-thirds of type 2 diabetic patients may be suffering from unrecognized sleep apnea . The main treatment option for sleep apnea is CPAP, in which a machine delivers air at a specific pressure via a connected to a facemask in order to splint the upper airway open and prevent further breathing disturbances during sleep. The breathing disturbances during sleep that result in sleep apnea have been linked to prediabetic conditions such as insulin resistance and as well as type 2 diabetes and cardiovascular complications.

The current study included 39 adults with sleep apnea and prediabetes who were randomized to two weeks of either CPAP treatment or placebo tablet. Before and after the treatment period, study participants underwent an oral glucose tolerance test, a test that measures body's ability to use glucose. A unique aspect of the study is that subjects slept each night in the research laboratory, ensuring optimal adherence to CPAP treatment. Glucose tolerance, , and , all markers for the risk of diabetes, were measured Subjects were also monitored for the quantity and quality of sleep, 24 hour blood pressure, heart rate, weight, energy expenditure and hormones affecting diabetes risk.

"Effective treatment of OSA is known to have a positive impact on a number of important health outcomes and in our study we observed beneficial effects on glucose metabolism," said principal investigator, Esra Tasali, MD, assistant professor of pulmonary and critical care medicine at the University of Chicago. This "proof of concept" study may provide essential information for designing larger multicenter clinical trials that will determine whether CPAP treatment could be a first line intervention to prevent or delay the development of . Our study adds to the current literature by demonstrating that CPAP treatment of sleep apnea in patients at risk for developing diabetes may lower this risk, and an assessment for sleep apnea may be appropriate as part of the clinical evaluation of patients with ," said Dr. Pamidi.

Explore further: Sleep apnea tied to insulin resistance in young, lean men

Related Stories

Sleep apnea tied to insulin resistance in young, lean men

August 29, 2012
(HealthDay)—In healthy, lean, young men, the presence of obstructive sleep apnea (OSA) correlates with insulin resistance and compensatory hyperinsulinemia to maintain normal glucose levels, according to a study published ...

Study shows that bedtime regularity predicts CPAP compliance

May 7, 2013
A new study suggests that regularity of bedtime prior to initiation of continuous positive airway pressure (CPAP) therapy is an important factor that may influence treatment compliance in adults with obstructive sleep apnea ...

Sleep apnea with polycystic ovary syndrome raises risk of prediabetes

June 26, 2012
Women with polycystic ovary syndrome (PCOS) who also have obstructive sleep apnea have at least three times the risk of having prediabetes compared with women who do not have PCOS, according to a new study. The results will ...

CPAP improves work productivity for sleep apnea patients

April 10, 2013
Continuous positive airway pressure is effective at increasing work productivity, according to a new study.

Researchers identify a potential new risk for sleep apnea: Asthma

May 19, 2013
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

Treatment of obstructive sleep apnea improves blood pressure in men

October 13, 2012
A new study suggests that when prescribed by physicians in routine practice and used appropriately by patients, treatment for obstructive sleep apnea (OSA) could reduce blood pressure in men with hypertension.

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.